Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06568549 · ClinicalTrials.gov registry record · Phase 4
Reduced Immunosuppression in Older Renal Transplant Recipients With Trugraf®/TRAC Monitoring (RIOT Trial): A Prospective, Randomized, Multicenter Trial.
A Phase 4 study of Kidney Transplantation and Mycophenolate Mofetil, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 350
- Enrollment target
- 3
- Study locations
NCT06568549 is a Phase 4 study of Kidney Transplantation and Mycophenolate Mofetil that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 350 participants, above the 257-participant average among 33 other Kidney Transplantation trials with a reported enrollment target (36% higher). The trial reports 3 study locations across 3 states.
The verdict
NCT06568549, a Phase 4 study of Kidney Transplantation and Mycophenolate Mofetil, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 350 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this research is to determine the safety and efficacy of withdrawing MMF (Mycophenolate Mofetil) in kidney transplant recipients who are 55 years or older at the time of receiving a kidney transplant. We are comparing them to patients who receive the standard of care Mycophenolate Mofetil.
Conditions Studied
Interventions
- DRUG Mycophenolate Mofetil (MMF) Maintenance Group
- DRUG Mycophenolate Mofetil (MMF) Withdrawal Group
Study Locations (3)
Arizona
- Mayo Clinic - Phoenix
Florida
- Mayo Clinic - Jacksonville
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 350 participants |
| Start Date | 2025-06-13 |
| Est. Completion | 2031-03-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06568549
The ClinicalTrials.gov registry entry for NCT06568549 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 350 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 257-participant average among 33 other Kidney Transplantation trials with a reported enrollment target (36% higher). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Kidney Transplantation appearing as the primary indexed condition, and to 2 interventions - of which Mycophenolate Mofetil (MMF) Maintenance Group is the first listed.
NCT06568549 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Arizona, Florida, Minnesota.
Frequently Asked Questions
What is clinical trial NCT06568549 about?
NCT06568549 is a clinical study titled "Reduced Immunosuppression in Older Renal Transplant Recipients With Trugraf®/TRAC Monitoring (RIOT Trial): A Prospective, Randomized, Multicenter Trial.". The purpose of this research is to determine the safety and efficacy of withdrawing MMF (Mycophenolate Mofetil) in kidney transplant recipients who are 55 years or older at the time of receiving a kidney transplant. We are comparing them to patients who receive the standard of care Mycophenolate Mof...
What is the current status of trial NCT06568549?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 350 participants. The study started on 2025-06-13. Estimated completion is 2031-03-31.
What conditions does trial NCT06568549 study?
This clinical trial studies the following conditions: Kidney Transplantation, Mycophenolate Mofetil.
What interventions are being tested in trial NCT06568549?
The interventions under investigation include: Mycophenolate Mofetil (MMF) Maintenance Group (DRUG), Mycophenolate Mofetil (MMF) Withdrawal Group (DRUG).
Who is sponsoring clinical trial NCT06568549?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06568549 being conducted?
This trial has 3 study locations across Arizona, Florida, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Kidney Transplantation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Envarsus XR® in Adolescent Renal Transplant Recipients
ACTIVE NOT RECRUITING · Phase 4
-
Safety/Efficacy of Induction Agents With Tacrolimus, MMF, and Rapid Steroid Withdrawal in Renal Transplant Recipients
COMPLETED · Phase 4
-
Calcineurin Inhibitor Avoidance With Thymoglobulin and Sirolimus in Kidney Transplantation
COMPLETED · Phase 4
-
Study of Therapeutic Monitoring of Mycophenolate Mofetil (MMF/CellCept) After Kidney Transplantation
COMPLETED · Phase 4
-
Shared Decision Making for Kidney Transplant Candidates to Plan for an Organ Offer Decision
RECRUITING · NA
-
Prehabilitation for Kidney Transplant Candidates
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.